Science

Toutes les opérations de Boreal Omega sont basées sur l’expérience et la science. Vous trouverez ici un échantillon de publications rigoureuses qui appuient les orientations de Boreal Omega.

La surpopulation des phoques et ses impacts ont fait l’objet de nombreuses études qui démontrent clairement l’urgence d’agir.

Impacts de la prédation du phoque sur l’écosystème marin du Golfe St-Laurent

  • Le phoque et les torts causés par Bardot [audio, 22 min.] (Mange ton Saint-Laurent!), 2024.

  • Comité sénatorial permanent des pêches et des océans. (2024). Assurer l’avenir de la chasse au phoque : passons à l’action. Sénat du Canada.

  • Sinclair, M., Power, M., Head, E., Li, W. K. W., McMahon, M., Mohn, R., O’Boyle, R., Swain, D., & Tremblay, J. (2015). Eastern Scotian Shelf trophic dynamics: A review of the evidence for diverse hypotheses. Progress in Oceanography, 138(Part A), 305–321.

  • Hammill, M. O., Stenson, G. B., Swain, D. P., & Benoît, H. P. (2014). Feeding by grey seals on endangered stocks of Atlantic cod and white hake. ICES Journal of Marine Science, 71(6), 1332–1341.

  • Comité sénatorial permanent des pêches et des océans. (2012). La gestion durable des populations de phoques gris : vers le rétablissement des stocks de morue et autres poissons de fond. Sénat du Canada.

  • Benoit, H., Gagné, J., Savenkoff, C., Ouellet, P., & Bourassa, M.-N. (2012). Rapport sur l’état des océans pour la zone de gestion intégrée du golfe du Saint-Laurent (GIGSL). Pêches et Océans Canada (MPO).

  • Benoît, H. P., Swain, D. P., Bowen, W. D., Breed, G. A., Hammill, M. O., & Harvey, V. (2011). Evaluating the potential for grey seal predation to explain elevated natural mortality in three fish species in the southern Gulf of St. Lawrence. Marine Ecology Progress Series, 442, 149–167.

  • O’Boyle, R., & Sinclair, M. (2012). Seal–cod interactions on the Eastern Scotian Shelf: Reconsideration of modelling assumptions. Fisheries Research, 115–116, 1–13.

  • Pêches et Océans Canada. (2010). Impacts des phoques gris sur les populations de poissons dans l’est du Canada. Gouvernement du Canada.

Cerveau

Maladie d’Alzheimer

  • Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Archives of Neurology, 60(7), 940–946.

  • Soderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991). Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease. Lipids, 26(6), 421–425.

  • Wang, W., Shinto, L., Connor, W. E., & Quinn, J. F. (2008). Nutritional biomarkers in Alzheimer’s disease: The association between carotenoids, n-3 fatty acids, and dementia severity. Journal of Alzheimer’s Disease, 13(1), 31–38.

  • Yurko-Mauro, K. (2010). Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Current Alzheimer Research, 7(3), 190–196.

Déclin cognitif

  • Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Migliorini, S., & Lodi, L. (2005). Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. European Journal of Clinical Investigation, 35(11), 691–699.

  • Gadoth, N. (2008). On fish oil and omega-3 supplementation in children: The role of such supplementation on attention and cognitive dysfunction. Brain and Development, 30(5), 309–312.

  • Cole, G. M., & Frautschy, S. A. (2010). DHA may prevent age-related dementia. Journal of Nutrition, 140(4), 869–874.

  • Van de Rest, O., Geleijnse, J. M., Kok, J. F., van Staveren, W. A., Dullemeijer, C., Olde Rikkert, M. G. M., Beekman, A. T. F., & de Groot, C. P. G. M. (2008). Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology, 71(6), 430–438.

Humeur et anxiété

  • Buydens-Branchey, L., Branchey, M., & Hibbeln, J. (2008). Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(2), 568–575.

  • Su, K.-P., Matsuoka, Y., & Pae, C.-U. (2015). Omega-3 polyunsaturated fatty acids in prevention of mood and anxiety disorders. Clinical Psychopharmacology and Neuroscience, 13(2), 129–137.

Dépression

  • Deacon, G., Kettle, C., Hayes, D., Dennis, C., & Tucci, J. (2017). Omega 3 polyunsaturated fatty acids and the treatment of depression. Critical Reviews in Food Science and Nutrition, 57(1), 212–223. https://doi.org/10.1080/10408398.2013.876959

  • Lespérance, F., Frasure-Smith, N., St-André, É., Turecki, G., Lespérance, P., & Wisniewski, S. R. (2010). The efficacy of omega-3 supplementation for major depression: A randomized controlled trial. The Journal of Clinical Psychiatry, 72(8), 1054–1062.

  • Maes, M., Christophe, A., Delanghe, J., Altamura, C., Neels, H., & Meltzer, H. Y. (1999). Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research, 85(3), 275–291.

  • McNamara, R. K., & Carlson, S. E. (2006). Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75(4–5), 329–349.

Autisme et syndrome d’Asperger

  • Salik, R., & Patrick, L. (2005). The effect of essential fatty acid supplementation on language development and learning skills in autism and Asperger’s syndrome. Autism-Asperger’s Digest, January–February, 36–37.

Trouble du déficit de l’attention avec ou sans hyperactivité (TDAH)

  • Matsudaira, T., Gow, R. V., Kelly, J., Murphy, C., Potts, L., Sumich, A., Ghebremeskel, K., Crawford, M. A., & Taylor, E. (2009). Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids, 80(2–3), 151–156.

Coeur

Crise cardiaque

  • Urabe, Y., Uchida, T., Harada, S., Nishimoto, Y., Tanaka, M., Ikeda, G., & Higashi, Y. (2013). Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy. Circulation Journal, 77(6), 1486–1492.

Maladies coronariennes

  • Whelton, S. P., He, J., Whelton, P. K., & Muntner, P. (2004). Meta-analysis of observational studies of fish intake and coronary heart disease. The American Journal of Cardiology, 93(9), 1119–1123.

Accidents vasculaires cérébraux

  • Chung, M., Balk, E., Lichtenstein, A., Chew, P., Kupelnick, B., Lawrence, A., DeVine, D., & Lau, J. (2004). Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease (Evidence Report/Technology Assessment No. 93, AHRQ Publication No. 04-E010-1). Agency for Healthcare Research and Quality.

  • Harris, W. S. (2007). International recommendations for consumption of long-chain omega-3 fatty acids. Journal of Cardiovascular Medicine, 8(Suppl. 1), S50–S52.

  • Laidlaw, M., Cockerline, C. A., & Rowe, W. J. (2014). A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction. Lipids in Health and Disease, 13, 99. https://doi.org/10.1186/1476-511X-13-99

  • Svensson, M., Schmidt, E. B., Jørgensen, K. A., & Christensen, J. H. (2006). N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: A randomized, placebo-controlled intervention trial. Clinical Journal of the American Society of Nephrology, 1(4), 780–786.

Cholestérol

  • Neubronner, J., Schuchardt, J. P., Kressel, G., Merkel, M., von Schacky, C., & Hahn, A. (2011). Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. European Journal of Clinical Nutrition, 65(2), 247–254.

  • Maki, K. C., Bobotas, G., Dicklin, M. R., Huebner, M., & Keane, W. F. (2017). Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables. Journal of Clinical Lipidology, 11(1), 102–109. https://doi.org/10.1016/j.jacl.2016.10.010

  • Dubey, P., Jayasooriya, A. P., & Cheema, S. K. (2011). Diets enriched in fish-oil or seal-oil have distinct effects on lipid levels and peroxidation in BioF1B hamsters. Nutrition and Metabolic Insights, 4, 11–18.

  • Skulas-Ray, A. C., Flock, M. R., Richter, C. K., Harris, W. S., West, S. G., & Kris-Etherton, P. M. (2015). Red blood cell docosapentaenoic acid (DPA n-3) is inversely associated with triglycerides and C-reactive protein (CRP) in healthy adults and dose-dependently increases following n-3 fatty acid supplementation. Nutrients, 7(8), 6390–6404. https://doi.org/10.3390/nu7085291

Hypertension

  • Appel, L. J., Miller, E. R., III, Seidler, A. J., & Whelton, P. K. (1993). Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Archives of Internal Medicine, 153(12), 1429–1438.

Athérosclérose

  • Flock, M., & Kris-Etherton, P. (2011). Dietary Guidelines for Americans 2010: Implications for cardiovascular disease. Current Atherosclerosis Reports, 13(6), 499–507.

  • Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2003). Omega-3 fatty acids and cardiovascular disease: New recommendations from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 151–152.

Grossesse et développement de l’enfant

Grossesse

  • Bishop, N. A., & Leblanc, C. P. (2017). Dietary intake of DHA and EPA in a group of pregnant women in the Moncton area. Canadian Journal of Dietetic Practice and Research, 78(2), 80–83.

  • Hanebutt, F., Demmelmair, H., Schiessl, B., Larqué, E., & Koletzko, B. (2008). Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clinical Nutrition, 27(5), 685–693.

  • Kanayasu-Toyoda, T., Morita, I., & Murota, S. (1996). Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostaglandins, Leukotrienes and Essential Fatty Acids, 54(5), 319–325.

  • Makrides, M. (2013). Understanding the effects of docosahexaenoic acid (DHA) supplementation during pregnancy on multiple outcomes from the DOMInO trial. Nutrition Reviews, 71(Suppl. 1), S7–S9.

  • Ostadrahimi, A., Mohammad-Alizadeh, S., Mirgafourvand, M., Yaghoubi, S., Shahrisa, E., & Farshbaf-Khalili, A. (2016). Effects of fish oil supplementation on gestational diabetes mellitus (GDM): A systematic review. Iranian Red Crescent Medical Journal, 18(11), e24690.

Allaitement

  • Juber, B. A., Jackson, K. H., Johnson, K. B., Harris, W. S., & Baack, M. L. (2017). Breast milk DHA levels may increase after informing women: A community-based cohort study from South Dakota USA. International Breastfeeding Journal, 12, 7.

  • Marszalek, J. R., & Lodish, H. F. (2005). Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: Breastmilk and fish are good for you. Annual Review of Cell and Developmental Biology, 21, 633–657.

Système immunitaire du bébé

  • Dunstan, J. A., Mori, T. A., Barden, A., Beilin, L. J., Taylor, A. L., Holt, P. G., & Prescott, S. L. (2003). Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial. Journal of Allergy and Clinical Immunology, 112(6), 1178–1184.

  • Dunstan, J. A., Roper, J., Mitoulas, L., Hartmann, P. E., Simmer, K., & Prescott, S. L. (2004). The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels, and fatty acid composition. Clinical and Experimental Allergy, 34(8), 1237–1242.

  • Bisgaard, H., Stokholm, J., Chawes, B. L., Vissing, N. H., Bjarnadóttir, E., Schoos, A.-M. M., Wolsk, H. M., Pedersen, T. M., Vinding, R. K., Thorsteinsdóttir, S., Folsgaard, N. V., Fink, N. R., Thorsen, J., Pedersen, A. G., Waage, J., Rasmussen, M. A., Stark, K. D., Olsen, S. F., & Bønnelykke, K. (2016). Fish oil–derived fatty acids in pregnancy and wheeze and asthma in offspring. New England Journal of Medicine, 375(26), 2530–2539.

Santé postnatale

  • Borja-Hart, N. L., & Marino, J. (2010). Role of omega-3 fatty acids for prevention or treatment of perinatal depression. Pharmacotherapy, 30(2), 210–216.

  • Da Rocha, C., & Kac, G. (2012). High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression. Maternal and Child Nutrition, 8(1), 36–48.

  • Gould, J. F., Best, K., & Makrides, M. (2017). Perinatal nutrition interventions and post-partum depressive symptoms. Journal of Affective Disorders, 224, 2–9.

  • Masoumi, S. Z., Kazemi, F., Tavakolian, S., Rahimi, A., Oshvandi, K., Soltanian, A., & Shobeiri, F. (2017). Effect of citalopram in combination with omega-3 on depression in post-menopausal women: A triple blind randomized controlled trial. Critical Reviews in Food Science and Nutrition, 57(1), 212–223.

  • Mills, M. D. (1999). The eye in childhood. American Family Physician, 60(3), 907–918.

  • Oh, R. (2005). Practical applications of fish oil (Ω-3 fatty acids) in primary care. Journal of the American Board of Family Practice, 18(1), 28–36.

Apprentissage

  • European Food Safety Authority. (2008). Scientific substantiation of a health claim related to docosahexaenoic acid (DHA) and arachidonic acid (ARA) and support of the neural development of the brain and eyes pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal, 6(6), 794.

  • Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999). Brain development during childhood and adolescence: A longitudinal MRI study. Nature Neuroscience, 2(10), 861–863.

  • Haag, M. (2003). Essential fatty acids and the brain. The Canadian Journal of Psychiatry, 48(3), 195–203.

  • Helland, I. B., Smith, L., Saarem, K., Saugstad, O. D., & Drevon, C. A. (2003). Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics, 111(1), e39–e44.

  • Uauy, R., Hoffmann, D. R., Peirano, P., Birch, D. G., & Birch, E. E. (2001). Essential fatty acids in visual and brain development. Lipids, 36(9), 885–895.

Inflammation et santé articulaire

Polyarthrite rhumatoïde

  • Kremer, J. M. (2000). n-3 Fatty acid supplements in rheumatoid arthritis. American Journal of Clinical Nutrition, 71(1 Suppl.), 349S–351S.

  • Olendzki, B., Leung, K., Van Buskirk, S., Aguiar-Alves, F., Schaefer, E., & Merriam, P. (2011). Treatment of rheumatoid arthritis with marine and botanical oils: Influence on serum lipids. Evidence-Based Complementary and Alternative Medicine, 2011, 827286.

  • Seddon, J. M., Cote, J., Davis, N., & Rosner, B. (2001). Dietary fat and risk for advanced age-related macular degeneration. Archives of Ophthalmology, 119(8), 1191–1199.

  • Volker, D., Fitzgerald, P., Major, G., & Garg, M. (2000). Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. The Journal of Rheumatology, 27(10), 2343–2346.

Maladie de Crohn

  • Lev-Tzion, R., Griffiths, A. M., Leder, O., & Turner, D. (2014). Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database of Systematic Reviews, 2, CD006320.

Colite ulcéreuse

  • Turner, D., Steinhart, A. H., & Griffiths, A. M. (2007). Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews, 3, CD006443.

Fibrose kystique

  • Oliver, C., & Jahnke, N. (2011). Omega-3 fatty acids for cystic fibrosis. Cochrane Database of Systematic Reviews, 8, CD002201.

Lupus érythémateux systémique

  • Walton, A. J. E., Snaith, M. L., Locniskar, M., Cumberland, A. G., Morrow, W. J. W., & Isenberg, D. A. (1991). Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 50(7), 463–466.

Inflammation

  • Simopoulos, A. P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition, 21(6), 495–505.

  • Barham, J. B., Edens, M. B., Fonteh, A. N., Johnson, M. M., Easter, L., & Chilton, F. H. (2000). Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. Journal of Nutrition, 130(8), 1925–1931.

  • Calder, P. C. (2006). n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. American Journal of Clinical Nutrition, 83(6 Suppl.), S1505–S1519.

  • Maroon, J. C., & Bost, J. W. (2006). Omega-3 fatty acids (fish oil) as an anti-inflammatory: An alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surgical Neurology, 65(4), 326–331.

Cancer

Général

  • Nakamura, K., Kariyazono, H., Komokata, T., Hamada, N., Sakata, R., & Yamada, K. (2005). Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer. Nutrition, 21(6), 639–645.

Prostate

  • Rose, D. P., & Connolly, J. M. (1999). Omega-3 fatty acids as cancer chemopreventive agents. Pharmacology & Therapeutics, 83(3), 217–244.

  • Terry, P., Lichtenstein, P., Feychting, M., Ahlbom, A., & Wolk, A. (2002). Fatty fish consumption and risk of prostate cancer. Nutrition and Cancer, 44(1), 1–6.

Colon

  • Anti, M., Armelao, F., Marra, G., Percesepe, A., Bartoli, G. M., Palozza, P., Parrella, P., Canetta, C., Gentiloni, N., & De Vitis, I. (1994). Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology, 107(6), 1709–1718.

  • Belluzzi, A., Brignola, C., Campieri, M., Pera, A., Boschi, S., & Miglioli, M. (1996). Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. New England Journal of Medicine, 334(24), 1557–1560.

Sein

  • Fabian, C. J., Kimler, B. F., & Hursting, S. D. (2015). Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Research, 17, 62.

Poumon

  • Finocchiaro, C., Segre, O., Fadda, M., Monge, T., Scigliano, M., Schena, M., Tinivella, M., Tiozzo, E., Catalano, M. G., Pugliese, M., Fortunati, N., Aragno, M., Muzio, G., Maggiora, M., Oraldi, M., & Canuto, R. A. (2012). Effect of n-3 fatty acids on patients with advanced lung cancer: A double-blind, placebo-controlled study. British Journal of Nutrition, 108(2), 327–333.

Autres

Fonction musculaire

  • Lewis, E. J. H., Radonic, P. W., Wolever, T. M. S., & Wells, G. D. (2015). 21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo. Journal of the International Society of Sports Nutrition, 12, 28.

  • Zebrowska, A., Mizia-Stec, K., Mizia, M., Gąsior, Z., & Poprzecki, S. (2015). Omega-3 fatty acids supplementation improves endothelial function and maximal oxygen uptake in endurance-trained athletes. European Journal of Sport Science, 15(4), 305–314.

Fatigue

  • Huffman, D. M., Altena, T. S., Mawhinney, T. P., & Thomas, T. R. (2004). Effect of n-3 fatty acids on free tryptophan and exercise fatigue. European Journal of Applied Physiology, 92(4–5), 584–591.

  • Leger, C., Guezennec, C.-Y., Hassini, N. K., & Satabin, P. (1992). Les acides gras phospholipidiques membranaires au cours de l’effort physique de longue durée avec ou sans apport nutritionnel d’huile de poissons. Cahiers de Nutrition et de Diététique, 27(2), 82–89.

Diabète

  • Hartweg, J., Perera, R., Montori, V., Dinneen, S., Neil, H. A., & Farmer, A. (2008). Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 1, CD003205.

Système immunitaire

  • Mann, N. J., O’Connell, S. L., Baldwin, K. M., Singh, I., & Meyer, B. J. (2010). Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids, 45(9), 799–806.

Système respiratoire

  • Leaf, A., & Rauch, C. R. (1988). Hypothesis: Omega-3 fatty acids and blood rheology: Implications for human aerobic performance. Annals of Sports Medicine, 4(1), 32–36.

  • Mickleborough, T. D., Lindley, M. R., & Montgomery, G. S. (2008). Effect of fish oil-derived omega-3 polyunsaturated fatty acid supplementation on exercise-induced bronchoconstriction and immune function in athletes. Physician and Sportsmedicine, 36(1), 11–17.

  • Zebrowska, A., Mizia-Stec, K., Mizia, M., Gąsior, Z., & Poprzecki, S. (2015). Omega-3 fatty acids supplementation improves endothelial function and maximal oxygen uptake in endurance-trained athletes. European Journal of Sport Science, 15(4), 305–314.

Système oculaire

  • Hodge, W., Barnes, D., Schachter, H. M., Pan, Y., Lowcock, E. C., Zhang, L., Sampson, M., Morrison, A., Tran, K., Miguelez, M., & Lewin, G. (2005). Effects of omega-3 fatty acids on eye health (Evidence Report/Technology Assessment No. 117, AHRQ No. 05-E008-2). Agency for Healthcare Research and Quality.

Peau

  • McCusker, M. M., & Grant-Kels, J. M. (2010). Healing fats of the skin: The structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clinics in Dermatology, 28(4), 440–451.

  • Soyland, E., Funk, J., Rajka, G., Sandberg, M., Thune, P., Rustad, L., Helland, S., Middelfart, K., Odu, S., Falk, E., & Prahl, H. (1994). Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis: A multicentre study. British Journal of Dermatology, 130(6), 757–764.

Avantages du DPA

  • Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., & Schmidt, E. B. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), 137–141.

  • European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies. (2012). Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal, 10(7), 2815.

  • Kaur, G., Cameron-Smith, D., Garg, M., & Sinclair, A. J. (2011). Docosapentaenoic acid (22:5n-3): A review of its biological effects. Progress in Lipid Research, 50(1), 28–34.

  • Mann, N. J., O’Connell, S. L., Baldwin, K. M., Singh, I., & Meyer, B. J. (2010). Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids, 45(9), 799–806.

  • Mason, R. P., & Sherratt, S. C. R. (2017). Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits. Biochemical and Biophysical Research Communications, 483(1), 425–429.

  • Miller, E., Kaur, G., Larsen, A., Loh, S. P., Linderborg, K., Weisinger, H. S., Turchini, G. M., Cameron-Smith, D., & Sinclair, A. J. (2013). A short-term n-3 DPA supplementation study in humans. European Journal of Nutrition, 52(3), 895–904.

  • Wang, J., Luo, X., Parcher, J. F., Haq, R. U., & Woodward, D. (2010). Effect of chemical randomization on positional distribution and stability of omega-3 oil triacylglycerols. Journal of Agricultural and Food Chemistry, 58(9), 5490–5495.

  • Kanayasu-Toyoda, T., Morita, I., & Murota, S. (1996). Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostaglandins, Leukotrienes and Essential Fatty Acids, 54(5), 319–325.

Vous pouvez trouver d’autres publications au Global Organization for EPA and DHA Omega-3s et au Canadian Seal Products